1 The striatum is a crucial site of action for the motor effects of cannabinoids (CBs). However, the electrophysiological consequences of activation of CB receptors on the striatal neurons have not been established. Here we report for the first time that the cannabimimetic aminoalkylindole WIN 55,212‐2 and the endogenous cannabinoid anandamide substantially depress corticostriatal glutamatergic synaptic transmission onto striatal neurons in the brain slice preparation. The selective CB1 receptor antagonist SR 141716 effectively reversed this inhibition. 2 WIN 55,212‐2 significantly increased the paired‐pulse facilitation of synaptically evoked EPSCs, while having no effect on the sensitivity of postsynaptic neurons to α‐amino‐3‐hydroxy‐5‐methylisoxazole‐4‐propionic acid. WIN 55,212‐2 also reduced the frequency of spontaneous, action potential‐dependent EPSCs (sEPSCs) without altering their amplitude distribution. 3 Superfusion of WIN 55,212‐2 elicited a membrane hyperpolarization accompanied by a decrease in input resistance. Both effects were blocked by intracellular caesium. In contrast, intracellular caesium failed to affect WIN 55,212‐2‐mediated synaptic inhibition. 4 The WIN 55,212‐2‐mediated synaptic inhibition was blocked by the Gi/o protein inhibitor pertussis toxin (PTX), but not by the GABAA receptor antagonist bicuculline or GABAB receptor antagonist SCH 50911. 5 Pretreatment with the N‐type Ca2+ channel antagonist ω‐conotoxin GVIA selectively abolished the WIN‐55,212‐2‐mediated synaptic inhibition. 6 These results suggest that cannabinoids depress the corticostriatal glutamatergic synaptic transmission through the activation of presynaptic CB1 receptors to inhibit N‐type Ca2+ channel activity, which in turn reduces glutamate release. The presynaptic action of cannabinoids is mediated by a PTX‐sensitive Gi/o protein‐coupled signalling pathway.
The Journal of Physiology – Wiley
Published: May 1, 2001
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera